Ketamine used in the therapy of depressive disorders impacts protein profile, proliferation rate, and phagocytosis resistance of enterococci
Tomasz Jarzembowski
Department of Medical Microbiology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid profileSearch for this author on
, Agnieszka Daca
Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid profileSearch for this author on
, Wiesław J. Cubała
Department of Psychiatry, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Orcid profileSearch for this author on
, and Aug 09, 2022
About this article
Article Category: Original Study
Published Online: Aug 09, 2022
Page range: 333 - 338
Received: Jan 03, 2022
Accepted: May 11, 2022
DOI: https://doi.org/10.2478/ahem-2022-0047
Keywords
© 2022 Tomasz Jarzembowski et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Jarzembowski, Tomasz
Department of Medical Microbiology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Daca, Agnieszka
Department of Pathology and Experimental Rheumatology, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Cubała, Wiesław J.
Department of Psychiatry, Faculty of Medicine, Medical University of GdanskGdansk, Poland
Bronk, Marek
Department of Clinical Microbiology, Hospital of the Medical University of GdanskPoland
Naumiuk, Łukasz
Department of Clinical Microbiology, Hospital of the Medical University of GdanskPoland